Drug Database
Back to search

France· FR:68070731

VALACICLOVIR ALMUS 500 mg, comprimé pelliculé sécable

A valaciclovir product containing chlorhydrate de valaciclovir, registered in France by SUN PHARMA FRANCE, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AB11

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVALACICLOVIR ALMUS 500 mg, comprimé p…ATCJ05AB11REGISTER NO.FR:68070731PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate de valaciclovirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Valaciclovir is registered in 18 of 19 countries.

Countries holding a registration under ATC J05AB11 (valaciclovir), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose
Search valaciclovir products by name

Valaciclovir · ATC J05AB11

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valaciclovir costs, country by country.

Normalised to the WHO defined daily dose (3 g), the median price runs from $4.81 in France to $31.05 in United States — a ×6.5 gap.

  • France: $4.81 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Valaciclovir · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • US United States$31.05 (acquisition cost)
  • CH Switzerland$12.40
  • IT Italy$9.73
  • ES Spain$7.89
  • FR France$4.81
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE VALACICLOVIR
Manufacturer
SUN PHARMA FRANCE
Country
France (FR)
ATC code
J05AB11
ATC class
Valaciclovir
Defined daily dose
3 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400939884370
    plaquette(s) PVC PVDC aluminium de 10 comprimé(s)
    EUR 7.04
  • cip13
    3400939884660
    plaquette(s) PVC PVDC aluminium de 42 comprimé(s)
    EUR 28.95

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

226 interactions on record for valaciclovir.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check valaciclovir against other medicinesHow interaction checks work

Valaciclovir · interactions on record

226 records

  • 16 severe
  • 29 moderate
  • 2 minor
  • 178 info

Most severe, free to view

  • TemsirolimusL01EG01severe
  • EverolimusL01EG02severe
  • SirolimusL01EG04severe
  • TemsirolimusL01XE09severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valaciclovir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valaciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Valaciclovir Actavis, Valaciclovir Allen
  • Belgium · Valaciclovir Ab, Valaciclovir Sandoz
  • Bulgaria · Валтрекс
  • Cyprus · Valtrex
  • Czechia · Valaciclovir +pharma, Valacilovir Viatris
  • Germany · Valaciclovir 1 A Pharma, Valaciclovir Aurobindo
  • Denmark · Valaciclovir "sandoz", Valaciclovir 1a Farma
  • Estonia · Valaciclovir Actavis, Valtrex
  • Spain · Tridiavir, Valaciclovir Almus
  • Finland · Flushnil, Valaciclovir Ratiopharm
  • United Kingdom (Northern Ireland) · Valaciclovir Accord Healthcare, Valaciclovir Aristo
  • Greece · Valomed, Valtrex
  • Ireland · Valaciclovir Accord Healthcare Ireland, Valaciclovir Bluefish
  • Iceland · Valablis Forte, Valablis Normal
  • Italy · Talavir, Valaciclovir Aurobindo
  • Lithuania · Valaciclovir Actavis, Valtrex
  • Luxembourg · Zelitrex
  • Latvia · Valaciclovir Actavis, Valtrex
  • Netherlands · Valaciclovir Focus, Valaciclovir Hydrochloride Hydrate Aurobindo
  • Norway · Valaciclovir Sandoz, Valaciclovir Viatris
  • Poland · Vaciclor
  • Portugal · Valaciclovir Arpedex, Valaciclovir Aurobindo
  • Romania · Valaciclovir Arena, Valtrex
  • Sweden · Valaciclovir Actavis, Valaciclovir Bluefish
  • Slovenia · Valtrex
  • Slovakia · Valtrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8c115b6-fa42-4677-ae7d-45df110cb3fe
GET /v1/drugs/b8c115b6-fa42-4677-ae7d-45df110cb3fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68070731",
  "date_amm": "2009-11-02",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE VALACICLOVIR",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about valaciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console